SES and SpeQtral Sign MoU to Advance Global Quantum-Secure Communications
An interoperable Optical Ground Station will provide a long-distance Quantum Key Distribution link between Asia and Europe to scale next-generation cybersecurity and services
SES and SpeQtral signed a Memorandum of Understanding (MoU) to develop an interoperable Optical Ground Station (OGS) to establish long-distance satellite-based Quantum Key Distribution (QKD) between Asia and Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250328851677/en/
SES's CEO Adel Al-Saleh and SpeQtral's CEO Chune Yang Lum sign a Memorandum of Understanding to develop an interoperable Optical Ground Station to establish long-distance satellite-based Quantum Key Distribution between Asia and Europe.
Under the agreement, the development of an interoperable OGS will enable SES and SpeQtral to connect both companies’ current and future QKD satellite missions, resulting in easier access to, and diversity in the supply of long-distance QKD to end users in Asia, Europe and other future compatible ground stations worldwide. The integration of this proposed OGS with Singapore’s fibre-QKD network will help future customers integrate their networks with satellite QKD networks and demonstrate a practical pathway towards enabling a global QKD connectivity once the QKD satellites are operational.
SES and SpeQtral collaboration will reduce costs associated with quantum communication infrastructure, bridge a critical gap in the QKD service availability and lower barriers for global deployment and adoption.
The first such OGS is anticipated to be built in Singapore which already hosts a vibrant seedbed of quantum-safe activities including the National Quantum Safe Network Plus (NQSN+) initiative driven by Singapore’s Infocomm Media Development Authority (IMDA).
SES and SpeQtral’s Expertise in QKD
Fibre-based QKD networks that are being deployed in major cities around the world will require a satellite-based QKD solution to form an interconnected global QKD network.
QKD satellites operate in Sun-Synchronous Orbits approximately 500 km away from the Earth’s surface, enabling global interconnectivity and laying the foundation for highly secure communications in the age of quantum computing.
SES, in collaboration with a consortium of European partners, is leading the development of the EAGLE-1 project to enable early access to long-distance QKD for ultra-secure data transmissions. The project, which includes both satellite and ground infrastructure, is co-funded by ESA national contributions and the European Commission, reinforcing Europe's commitment to advancing quantum-secure communications.
SpeQtral is working on two QKD satellites, SpeQtre and SpeQtral-1, which are supported by the Office for Space Technology & Industry, Singapore (OSTIn). SpeQtre, a joint Singapore-UK mission set for launch later this year, will host SpeQtral’s space-qualified quantum-optics system which enables the establishment of quantum-secure encryption keys. OSTIn’s strong support for technological development in advanced space-based capabilities has played an important role in enabling local startups like SpeQtral, foster impactful international partnerships with the potential to shape the global quantum-security industry.
The MoU agreement was signed by the CEOs of both companies in Betzdorf, Luxembourg, during the State visit of Singapore’s President Tharman Shanmugaratnam to the Grand Duchy of Luxembourg.
Adel Al-Saleh, CEO of SES said, “Satellite-enabled Quantum Key Distribution is a fundamental technology for next-generation cyber security, allowing long-distance transmission of encryption keys. At SES we are delighted to bring our innovative expertise in developing secure, interoperable networked solutions, joining efforts with like-minded ecosystem partner SpeQtral in implementing the next milestone of our quantum-secure vision. The agreement allows SES to expand into non-EU markets and serve commercial customers, including facilitating secure exchanges between entities based across different geographies.”
Chune Yang Lum, CEO of SpeQtral, said: "Our partnership with SES represents a significant step towards realising commercially viable space-based QKD. It is important that we build on each other’s expertise, to unlock synergies in this initial phase of enabling the interconnection of localised fibre-based quantum networks. By developing a shared OGS infrastructure, we are reducing costs and strengthening the foundation for a truly global quantum-secure network."
Mr Jonathan Hung, Executive Director at OSTIn said: “The collaboration between SpeQtral and SES marks a significant milestone in Singapore's quantum technology landscape that will strengthen secure global communications for the future. The partnership leverages SpeQtral’s strengths as one of the first quantum key distribution (QKD) companies, together with SES’s satellite QKD expertise and position of a global content and connectivity solutions provider - to make quantum communications more accessible worldwide and allow seamless services for end-users in Asia and Europe. We welcome more partnerships with companies to strengthen Singapore’s position at the forefront of quantum communications innovation and commercialisation.”
Follow us on:
LinkedIn | Facebook | YouTube | X | Instagram
About SES
SES has a bold vision to deliver amazing experiences everywhere on Earth by distributing the highest quality video content and providing seamless data connectivity services around the world. As a provider of global content and connectivity solutions, SES owns and operates a geosynchronous orbit fleet and medium earth orbit (GEO-MEO) constellation of satellites, offering a combination of global coverage and high performance services. By using its intelligent, cloud-enabled network, SES delivers high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners around the world. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com
About SpeQtral
SpeQtral is a pioneer in quantum communications, with a vision to build and deploy global quantum networks. SpeQtral develops quantum-secure products and services designed to protect sovereign and enterprise telecommunication networks against classical, as well as future quantum-based cyber-attacks on cryptography. Combining both terrestrial and space-based solutions, SpeQtral aims to secure the world’s networks against the threats posed by the imminent quantum revolution and drive innovation in quantum communications that will serve as the building blocks for the future quantum internet. For more information, visit: https://speqtralquantum.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250328851677/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom